4//SEC Filing
Warren Marshelle Smith 4
Accession 0001209191-23-005077
CIK 0001604477other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:46 PM ET
Size
5.5 KB
Accession
0001209191-23-005077
Insider Transaction Report
Form 4
Warren Marshelle Smith
Chief Medical Officer
Transactions
- Award
Stock Option
2023-01-24+261,000→ 261,000 totalExercise: $0.73Exp: 2033-01-24→ Common Stock (261,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying securities on January 24, 2024 and in 36 substantially equal monthly installments thereafter, subject to limited acceleration upon involuntary termination.
Documents
Issuer
SQZ Biotechnologies Co
CIK 0001604477
Entity typeother
Related Parties
1- filerCIK 0001932203
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 4:46 PM ET
- Size
- 5.5 KB